You are here

NetraMark Holdings Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
AIAI
CSE Index: 
Currency: 

NetraMark Holdings is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of NetraMark Holdings Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit www.nurosene.com.

 

You are here

NetraMark Holdings Inc. (AIAI)

SEDAR Information

Company Info

Address
101-1655 Dupont Street
Toronto, ON M6P 3T1
Canada
Phone
403-681-2549
Email
swapan@nurosene.com
Website
https://www.netramark.com/
Listing date
Monday, June 7, 2021
Transfer Agent
Odyssey Trust Company
Email
george@netramark.com

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
48,117,522
Reserved for Issuance: 
6,521,684

Company Officers

George Achilleos, Chief Executive Officer
Swapan Kakumanu, Chief Financial Officer

Bulletins

30/01/2023

2023-0142 - Name and Symbol Change - Nurosene Health Inc. (MEND)

le 30 janvier/January 2023

Nurosene Health Inc. (MEND) has announced a name and symbol change to NetraMark Holdings Inc. (AIAI).

Advertisement

Publicité

Latest CSE News